G2/M checkpoints ensure the proper timing of cell mitosis. We previously reported that p38 mitogen-activated protein kinase (MAPK) activation is essential for stress-induced G2 arrest in the U-2OS osteosarcoma cell line, but the molecular mechanism was obscure. Here, using the T7 phage display system, we find p38 directly binds to human polycomb protein 2 (HPC2), and arsenate-induced G2 arrest in U-2OS cell is p38-and phosphorylation of HPC2-dependent. Phosphorylation of HPC2 at threonine 495 is required for recruiting Ring1 and Rb family proteins to form the polycomb repressive complex (PRC), and PRC is required for arsenate-induced downregulation of CDC2 expression. Thus, p38 MAPK regulates cell cycle progression through phosphorylation of HPC2 to mediate transcriptional repression, providing a mechanistic link for arsenate-induced transcriptional silencing.
Arsenate has been used to treat malignancies since the 18th century [1] . It is a chemical analog of phosphorus, and a unique feature of arsenate is its extremely paradoxical abilities: it is toxic to humans, animals, and plants, but it can kill some cancers; most recently, it has been found to have striking efficacy in the treatment of acute promyelocytic leukemia [2] . However, the mechanism(s) underlying this therapeutic effect remain unclear.
One of the cellular pathways activated by arsenate is p38 mitogen-activated protein kinase (MAPK) [3] . This is a primary signaling pathway that is also activated by other stressors such as UV irradiation [4] . We previously reported that activation of p38 in response to c-irradiation induced cell cycle arrest followed by apoptosis in U-2OS cells [5] . We found that inhibiting p38 disrupts the DNA damage checkpoint [5] . Here, using T7 phage display system, we found that p38 binds to human polycomb protein 2 (HPC2) which may represent the molecular mechanism behind p38 activation-induced cell cycle arrest and apoptosis.
Human polycomb protein 2 was first found to be a repressor of proto-oncogenes, interfering with cellular transformation and resulting in apoptosis in human U-2OS osteosarcoma cells [6] . Later studies found that HPC2 co-localizes to the nuclear Polycomb repressor complex and cooperates with Rb family members to arrest cells and cause apoptosis [7] . Anjali Dahiya et al., reported that HPC2 interacted with Ring1, mediating the assembly of protein complexes that Abbreviations HDAC, histone deacetylase; HPC2, human polycomb protein 2; MAPK, mitogen-activated protein kinase; PDSM, phosphorylation-dependent sumoylation motif; PI, propidium iodide; PRC1, polycomb repressive complex 1. target genes such as cyclin A, cyclin E, and cdc2 genes which regulate cell cycle progression. In p16 À/À U-2OS cells, a complex comprised of Rb-HPC2-Ring1 appears to arrest cells in G2 and represses expression of cyclin A and Cdc2 but not cycline E [7] . Here, we report that arsenate-induced G2 arrest in U-2OS cells is p38 MAPK and HPC2-dependent. Activation of p38 MAPK induces phosphorylation of HPC2 and the ensuing recruitment of the Ring1 and Rb complex. Mutation of the p38 phosphorylation site on HPC2 attenuates arsenate-induced binding activity to Ring1 and Rb and arsenate-induced G2 arrest. Importantly, mutation of HPC2 phosphorylation sites could protect cells from arsenate-induced cell apoptosis. Arsenateinduced repression of CDC2 expression might explain the G2 arrest, and downregulation of CDC2 expression is dependent on p38 phosphorylation of HPC2. Thus, we identified a new signaling pathway involved in arsenateinduced G2 arrest: p38 MAPK ? HPC2 phosphorylation ? HPC2/Ring1/Rb complex ? CDC2 expression ↓? G2 arrest ? apoptosis.
Materials and methods

T7 phage display system
T7 phage display system was transformed with human liver and lung cDNA libraries and subjected to screening with a His-tag fusion protein p38 MAPK and Ni-NTA resin. The product was eluted, amplified, and identified according to the manual provided by the manufacturer (Novagen, Darmstadt, Germany).
Cell culture, transient transfections, and expression vectors
Cells were grown in Gibco's Mccoy 5A's medium supplemented with 10% (v/v) fetal bovine serum and 1% (v/v) penicillin/streptomycin. Transfection was performed using the Lipofectamine 2000 (Invitrogen, California, USA) reagents according to the manufacturer's instructions. FlagRb, Ring1-GST, HPC2-V5, HPC2 point mutants were cloned using standard procedures. The potential phosphorylated sites of HPC2 by p38 were predicted with NetPhosK1.0 (http://www.cbs.dtu.dk/services/NetPhosK/).
Co-immunoprecipitation and western blotting
For detection of the HPC2-Rb-Ring1-p38 complexes, U-2OS cells were co-transfected with 8 lg of Rb-Flag expression vector, 8 lg HPC2-V5, and 8 lg of Ring1-GST expression vector. Cells were harvested 36 h later in lysis buffer. Lysates were pre-RB protein cleared by 30-min incubation with sepharose beads (Sigma-Aldrich, St. Louis, MO, USA). Cleared lysates were immunoprecipitated with a monoclonal anti-V5 antibody conjugated to agarose beads (Santa Cruz, Dallas, TX, USA). Precipitates were washed three times with lysis buffer and then subjected to SDS electrophoresis. Proteins were then immunoblotted with an anti-Flag antibody (Babco, Richmond, CA, USA), followed by an anti-GST polyclonal antibody (Santa Cruz) and anti-p38 monoclonal antibody (Cell Signaling Technology, Danvers, MA, USA). For detection of the binding domain responsible for the interaction of HPC2 and p38, the different truncate HPC2-V5 expression vector was transfected to U-2OS cells, followed by immunoprecipation of truncate HPC2-V5 with a monoclonal V5 antibody conjugated to agarose beads. Precipitates were then subjected to immunoblotting to detect p38 binding. The Phosphorylation site and Sumolyation site responsible for formation of HPC2-Ring1-Rb complex also were detected by immuoprecitation: 8 lg HPC2 mutation expression vector, 8 lg Rb-Flag expression vector, and 8 lg Ring1-GST expression vector were co-transfected to U-2OS cells, mutated HPC2-V5 was immunoprecipitated with monoclonal V5 antibody conjugated agarose beads (Santa Cruz), and followed by immunoblotting for Ring1-GST and Rb-flag (Santa Cruz).
Immunocolocalization
U-2OS cells were transfected with 2 lg HPC2-V5 expression vector and incubated with arsenate for 10, 30, 60, and 240 min at 37°C. Cells were washed in PBS and permeabilized with 4% formaldehyde (freshly prepared from paraformaldehyde) and 0.5% Triton X-100 for 5 min on ice. Cells were then blocked in DAKO Protein Block serum-Free Ready to Use (DAKO, Carpinteria, CA, USA) for 20 min. Cells were incubated with Texas red-conjugated p38 antibody, FITC-conjugated V5 antibody, and DAPI staining. Cells were imaged with a Leica TCS SP2 laser confocal scanning microscope (Wetzlar, Germany) and images were analyzed with IMAGE PRO PLUS 7.0 (Media Cybernetics, Inc., Rockville, MD, USA). Immunocolocalization studies of HPC2-V5 and Ring1-GST, truncate HPC2-V5 and p38, Rb-flag and Ring1-GST were done using their p38 antibody from Cell Signaling Technology, V5 antibody from Invitrogen, GST antibody from Santa Cruz, and Flag antibody from Sigma as described above.
Kinase assay
Assays were performed with purified phosphorylated p38-flag, HPC2-His, and 10 mM ATP in 50 mL of kinase buffer at 37°C for 1 h. Kinase activity was measured by monoclonal antibody toward Phospho-Threonine-Proline peptide (Cell Signaling Technology). The phosphorylated p38 was purified with p38 MAPK kinase activity kit (SigmaAldrich). antibody conjugated agarose and the precipitated p38 were determined by western blot. The lower panel shows the input, as revealed by direct lysis of cells in SDS sample buffer; (B) Quantitative analysis of p38 band; (C) U-2OS cells were stimulated with 5.0 lM sodium arsenite and with or without p38 inhibitor SB203580. Cell lysates were subjected to immunoprecipitation with anti-V5 antibody; precipitated p38 were determined by western blot; (D) Quantitative analysis of p38 band; (E) U-2OS cells were stimulated with 5.0 lM sodium arsenite and with or without adenovirus MKK3/6 (A). Cell lysates were subjected to immunoprecipitation with anti-HPC2 antibody; precipitated p38 were determined by western blot; (F) Quantitative analysis of p38 band; (G) U-2OS cells were stimulated with or without 5.0 lM sodium arsenite. Cell lysates were subjected to immunoprecipitation with anti-HPC2 antibody; precipitated p38 were determined by western blot; (H) Quantitative analysis of p38 band; (I) U-2OS cells were stimulated with or without adenovirus MKK6b(E). Cell lysates were subjected to immunoprecipitation with anti-HPC2 antibody; precipitated p38 were determined by western blot; (J) Quantitative analysis of p38 band; (K) U-2OS cells were transfected with HPC2-V5 expressing vector and treated with 5.0 lM sodium arsenite for 0, 30, 60, 120, and 240 min. Cells were fixed and incubated with Texas red-conjugated p38 antibody and FITC-conjugated V5 antibody, followed by analysis of cells by confocal microscopy for the distribution of both proteins. Scale bar = 10 lm; (L) U-2OS cells were transfected with HPC2-V5 expressing vector and treated with adenovirus MKK6b (E). Cells were fixed and incubated with Texas red-conjugated p38 antibody and FITC-conjugated V5 antibody, followed by analysis of cells by confocal microscopy for the distribution of both proteins. Scale bar = 10 lm; (M) U-2OS cells were stimulated with 5.0 lM arsenate for 1 h. Cells were fixed and incubated with Texas red-conjugated HPC2 antibody and FITC conjugated p38 antibody. The distribution of two molecules was observed with confocal microscopy. *P < 0.05, ***P < 0.001, ****P < 0.0001.
Dual luciferase reporter assay
CDC2 firefly reporter plasmid was a gift from C. K. Glass, University of Southern California, Los Angeles, CA [8] . Dual reporter luciferase assay was manipulated as manual of Promega. U-2OS cells were cultured at a density of 2 9 10 4 cells/well in 96-well culture plates and transfected with 0.2 lg of CDC2 firefly-luciferase reporter construct and the internal control vector pRL-TK according to the manufacturer's protocol. Forty-eight hours post-transfection, luciferase activity was measured and normalized to renilla luciferase activity in cells co-transfected with the reporter construct and the control vector. 
Flow cytometry
Western blot analysis
The results of western blot were analyzed by IMAGE J program (Wayne Rasband, NIH, Baltimore, MD, USA). The intensity of each band's fluorescence was normalized by its area compared to internal control; images in the figures were representative of three independent experiments.
Data analysis
Statistical analysis was performed by ANOVA with a post hoc LSD test. A value of P < 0.05 was considered significant. (*P < 0.05, **P < 0.01, ***P < 0.001).
Results
P38 interacts with HPC2 in vitro
To screen and identify proteins that interact with p38 MAPKs, we used T7-phage display screening system. His-tagged fusion protein p38 was used to coat Ni-NTA resin, which served as the media for screening human lung and liver T7 phage cDNA libraries. After screening, the inserted gene fragments were sequenced Fig. 2 . The SUMO-binding domain of HPC2 is responsible to its interaction with p38. (A) Schematic representation of hPc2 fragments with its conservation in vertebrates. Important motifs and domains are marked as indicated; (B) U-2OS cells were transfected with truncate HPC2-V5 expressing vector and induced by arsenate for 30 min. Cells were lysated and precipitated with V5 antibody conjugated agarose and the precipitated p38 were determined by western blot. The lower panel shows the input, as revealed by direct lysis of cells in SDS sample buffer; (C) Quantitative analysis of p38 band, n = 3. **P < 0.01, ****P < 0.0001. and analyzed with BLAST program in Genbank. Fortysix clones were found to encode proteins, which include kinases, transcriptional regulator, cytoskeletonrelated molecules, ion-channel elements, and HPC2 is one of those candidates.
HPC2 binds to p38 MAPK in vivo
To confirm the result of the T7 phage system, we overexpressed HPC2-V5 singly in U-2OS cells and stimulated cells with 5 lM sodium arsenite, and HPC2 was immuneprecipitated with V5 antibody. Western blots of p38 indicate that HPC2 binds to p38 when cells are activated by arsenate in a time-dependent manner (Fig. 1A) . Confocal microscopy confirmed that HPC2 is present in nuclei of untreated cells, while p38 is in the cytosol. After exposure to arsenate, p38 MAPK migrated to nuclei and bound to HPC2 (yellow color in merged images, Fig. 1K ). While, inhibition of p38 kinase activity with specific inhibitor SB203580 or adenovirus which constitutively express dominant negative form of p38 upstream kinase could reduce the interaction between p38 and HPC2. The interaction between endogenous p38 and HPC2 induced by arsenate were also proved with immunoprecipitation and confocal microscopy in U2OS cells (Fig. 1G,M) . We also found that activation of p38 by adenovirus-MKK6b (E), a constitutively activating form of p38 upstream kinase, could induce interaction between p38 and HPC2 (Fig. 1I,L) .
P38 MAPK binds to HPC2 at its Sumo-binding domain
In order to investigate the binding motif of HPC2, we constructed truncated HPC2 expression vectors according to the conserved domain of HPC2 and overexpressed them in U-2OS cells ( Fig. 2A) [9] . Immunoprecipitation using anti-V5 tag and western blots against p38 MAPK (Fig. 2B) shows that without the HPC2 Sumo-binding motif domain, p38 cannot bind to HPC2. Moreover, HPC2 sumo-binding motif could bind to p38 independently, which suggest that p38 bind to HPC2 at its Sumo-binding domain. Fig. 3 . p38 phosphorylates HPC2 in vitro and in vivo. (A) Purified total p38-flag, phosphorylated p38 were incubated with ATF2-His, respectively, under 10 mM ATP, 37°C for 1 h. Phosphorylated level of ATF2 was observed with western blot against phosphorylated threonine/serine-proline motif; (B) Purified total p38-flag, phosphorylated p38 were incubated with purified HPC2-His, respectively, under 10 mM ATP, 37°C for 1 h. Phosphorylated level of HPC2 was observed with western blot against phosphorylated threonine/serine-proline motif; (C) Quantitative analysis of phosphorylated HPC2 band, n = 3; (D) HPC2-V5 overexpressed HEK293 cells were stimulated with 5.0 lM sodium arsenite or arsenate plus SB203580. HPC2-V5 were precipitated and subjected to western blot to determine phosphorylated level; (E) Quantitative analysis of phosphorylated HPC2 band, n = 3; (F) HPC2-V5 wild-type, HPC2/T495A mutant and HPC2/S291A mutant were co-overexpressed with p38-flag in HEK293 cells, respectively. After transfection, 293 cells were stimulated with adenovirus MKK6b(E). Cells were lysated and subscribed to immunoprecipitation with anti-V5 antibody. Phosphorylation of precipitated HPC2-V5 were determined by western blot with antibody against phosphorylated threonine/serine-proline motif; (G) Quantitative analysis of phosphorylated HPC2 band, n = 3. *P < 0.05, ****P < 0.001.
P38 phosphorylates HPC2 at threonine-495
According to the bioinformatics tool NetPhosK1.0 (http://www.cbs.dtu.dk/services/NetPhosK/) and NetworKIN (www.networkin.info), there are several amino acid residues within HPC2 might be potential p38 phosphorylated sites [10, 11] . Threonine-495 (T495) site is the most likely site that could be phosphorylated by p38. Hence, kinase assay was carried out to investigate whether HPC2 is downstream substrate of p38. In our results, purified phosphorylated p38 could phosphorylate HPC2 at proline-directed threonine sites in vitro (Fig. 3B) . We also found that p38-specific inhibitor SB203580 could inhibit phosphorylation of HPC2-V5 by p38-flag in U-2OS cells with immunoprecipitation assay (Fig. 3D) . According to the prediction, T495 site of HPC2 is the most likely phosphorylation site of p38. We constructed HPC2/T495A mutant whose threonine-495 amino acid residue was mutated to alanine. We also construct another mutant HPC2/S291A which is also a potential phosphorylated site by p38 within HPC2. It is found that phosphorylated level of HPC2/T495A mutant was weaker than wild-type HPC2 and another mutant HPC2/S291A when stimulated with p38-activating adenovirus-MKK6b (E) (Fig. 3F) .
HPC2 binds to Ring1 and Rb when cells are exposed to arsenate
It has been reported that HPC2 binds to Ring1 and Rb to form Polycomb repressive complex 1 (PRC1) [7] . Figure 4 shows that HPC2 binds to Ring1 when cells were activated by arsenate. Immunoprecipitation and western blot analyses (Fig. 4A ) and confocal microscopy experiments (Fig. 4C) showed that HPC2 binds to Ring1 under steady-state conditions and that this binding is enhanced in cells exposed to arsenate. Figure 4 shows that in the Rb/Ring1/HPC2 complex, HPC2 not only binds to Ring1 but also to Rb. Overexpression of flag-tagged Rb, GST-tagged Ring1, and expressing vector and Ring1-GST expressing vector, and cells were stimulated by arsenate at 0, 30, 60, 120, and 240 min. Cells were lysated and precipitated with V5 antibody conjugated agarose and the precipitated Ring1-GST were determined by western blot as shown. The lower panel shows the input, as revealed by direct lysis of cells in SDS sample buffer; (B) Quantitative analysis of phosphorylated Ring1-GST band, n = 3; (C) U-2OS cells were co-transfected with HPC2-V5-expressing vector and Ring1-GST-expressing vector. Cells were treated with 5.0 lM arsenate for 30 min. Cells were fixed and stained with Texas red-conjugated GST antibody and FITC-conjugated V5 antibody, the nucleus was shown with DAPI staining, followed by analysis of cells by confocal microscopy for the distribution of both proteins. Scale bar = 10 lm; (D) U-2OS cells were co-transfected with HPC2-V5-expressing vector, Rb-flag-expressing vector, and Ring1-GST-expressing vecotr, and cells were stimulated by arsenate for 30 min. Cells were lysated and precipitated with V5 antibody-conjugated agarose and the precipitated Ring1-GST and Rb-flag were determined by western blot as shown. The lower panel shows the input, as revealed by direct lysis of cells in SDS sample buffer; (E) U-2OS cells were co-transfected with HPC2-V5-expressing vector, Rb-flagexpressing vector, and Ring1-GST-expressing vector. Cells were treated with 5.0 lM arsenate for 30 min. Cells were fixed and stained with Texas red-conjugated GST antibody and FITC-conjugated Flag antibody, the nucleus was shown with DAPI staining, followed by analysis of cells by confocal microscopy for the distribution of both proteins. Scale bar = 10 lm.
V5-tagged HPC2 in U-2OS cells, immunoprecipitation pulldown of HPC2 and western blots against the other two proteins demonstrated their mutual association (Fig. 4D) , and these results have been confirmed by confocal microscopy (Fig. 4E) .
HPC2 binding to Ring1 is phosphorylation-and Sumoylation-dependent
Mitogen-activated protein kinases are proline-preferring, so we constructed mutated HPC2 with serine or threonine mutated to alanine. Overexpression of these constructs in U-2OS cells revealed that HPC2 did not bind to Ring1 in cells overexpressing HPC2/T495A. Figure 5A shows that in immunoprecipitated HPC2/ T495A-V5, the intensity of staining in western blots against Ring1-GST is substantially diminished compared to HPC2/S291A-V5 used as a control (other mutation results not shown). To confirm the importance of phosphorylation of HPC2 at the 495 site, a phospho-mimic of 495 T to glutamic acid (E) was used and the overexpression of HPC2/T495E indeed induced their binding to Ring1 without arsenate stimulation (Fig. 5C ).
Sistonen and colleagues [12] reported that a phosphorylation-dependent sumoylation motif (PDSM), composed of a SUMO consensus sequence and an adjacent proline-directed phosphorylation motif ΨKxExxSP (Ψ, large hydrophobic residue; K, lysine; E, Glutamic acid; X, any amino acid; P, Proline). Studying the amino acid sequence of HPC2, it was determined that there is a PDSM at the T495 site, though it is ΨKxExxTP, instead of ΨKxExxSP. We constructed a K492R mutant and with overexpression of this mutated HPC2, Ring1 binding was greatly diminished, indicating that phosphorylation Fig. 5 . Phosphorylation of HPC2 at threonine 495 is responsible for interaction of HPC2 and Ring1. (A) U-2OS cells were co-transfected with HPC2-V5-expressing vector, HPC2/T495A, HPC2/S291A, and HPC2/K492R with Ring1-GST-expressing vector, respectively. Cells were stimulated by arsenate for 30 min. Cells were lysated and precipitated with V5 antibody-conjugated agarose and the precipitated Ring1-GST were determined by western blot. The lower panel shows the input, as revealed by direct lysis of cells in SDS sample buffer; (B) Quantitative analysis of phosphorylated Ring1-GST band, n = 3; (C) U-2OS cells were co-transfected with HPC2-V5-expressing vector, HPC2/T495A, HPC2/T495E, HPC2/S291A, and HPC2/K492R with Ring1-GST-expressing vector, respectively. Cells were stimulated by arsenate for 30 min. Cells were lysated and precipitated with V5 antibody conjugated agarose and the precipitated Ring1-GST were determined by western blot. The lower panel shows the input, as revealed by direct lysis of cells in SDS sample buffer; (D) Quantitative analysis of phosphorylated Ring1-GST band, n = 3; (E) U-2OS cells were co-transfected with V5 control vector, HPC2-V5-expressing vector, HPC2/T495A, and HPC2/S291A with Ring1-GST and Rb-flag-expressing vector, respectively. Cells were stimulated by arsenate for 30 min. Cells were lysated and precipitated with V5 antibody-conjugated agarose and the precipitated endogenous p38, Rb-flag, and Ring1-GST were determined by western blot as shown. The lower panel shows the input, as revealed by direct lysis of cells in SDS sample buffer. (F) Quantitative analysis of phosphorylated p38 band, n = 3. **P < 0.01. of HPC2 by p38 MAPK at T495 may induce sumoylation of HPC2 and that the arsenate-induced HPC2 binding to Ring1 was K492 sumoylationdependent (Fig. 5A,C) .
Phosphorylation of HPC2 at T495 does not affect its binding to p38 MAPK To confirm that the binding of Rb and Ring1 is p38 MAPK-dependent, we co-transfected cells with a dominant positive form of p38 MAPK upstream kinase, namely MKK6b(E) [5] , and V5-tagged HPC2, flagtagged Rb, and GST-tagged Ring1. Figure 5E shows that mutation of HPC2 at T495 also attenuated its binding to Rb and Ring1, but not to p38 MAPK itself. HPC2/S291A mutant, whose 291 serine was mutated to alanine, was a control vector of transfection.
Arsenate-induced U-2OS cell G2 arrest is p38 MAPK-and HPC2-dependent HPC2 binds to Ring1 and Rb forming PRC1, and PRC1 repressed CDC2 expression may lead to G2 arrest in p16 À/À cells [7] . Figure 6A shows that arsenate-induced G2 arrest was p38 MAPK-dependent, which was blocked by the p38 MAPK specific inhibitor, SB203580. Confirming the importance of p38 MAPK at arsenate-induced U-2OS G2 arrest, cells were exposed to the dominant positive adenoviral construct Ad-MKK6b(E) [5] which, as expected, induced G2 arrest. On the other hand, a control construct of Ad-MKK3/6(A), a dominant negative construct of p38 MAPK upstream kinase, had similar effect as p38 inhibitor (Fig. 6A) . Transfection of siRNA against HPC2 attenuated arsenate-induced cell G2 arrest, indicating that HPC2 was involved. Sham siRNA had no such effect (Fig. 6A) .
Arsenate-induced G2 arrest is T495 phosphorylation-dependent
In Fig. 6B , we tested all the mutated constructs of HPC2 potential p38-regulated phosphorylation sites, and only overexpression of HPC2/T495A blocked arsenate-induced G2 arrest. These results support the importance of HPC2 binding to Ring1 and Rb to form the PRC1, which may then repress CDC2 expression. Arsenate-induced suppression of CDC2 expression is HPC2 T495-dependent CDC2 is essential molecule for entry into mitosis in mammalian cells [13] . PRC1 regulates CDC2 and cyclin A but not cyclin E expression [7] . Figure 6D shows that exposing U-2OS cells to arsenate down-regulates CDC2 expression in a time-dependent manner, while cyclin A and cyclin E were unaffected. To confirm that arsenate regulation of CDC2 expression is HPC2 phosphorylation-dependent, we transfected U-2OS cells with HPC2/T495A-V5, which significantly induced CDC2 expression (Fig. 7A) . Dual luciferase reporter assay shows that HPC2/T495A could inhibit arsenate-induced CDC2 promoter inactivation (Fig. 7C) . Thus, CDC2 down-regulation induced by arsenate is HPC2 phosphorylation-dependent (at the T495 site).
P38/HPC2 pathway is involved in arsenateinduced U-2OS cell apoptosis
Arsenate stimulated U-2OS cells stepped into apoptosis eventually, while mutation of HPC2 at 495 threonine amino acid residue would inhibit this arsenate-induced apoptosis (Fig. 7D,E) . Mutation of HPC2 at 291 serine amino acid residue as control had no such effect.
Discussion
HPC2 has been reported to be phosphorylated by AKT1 [14] and HIPK2 [15] . Phosphorylation of HPC2 by AKT1 at S415 and S434 sites was believed to involve HPC2-mediated phosphorylation of CtBP1, and ensuing ubiquitinylation of CtBP1, thereby targeting CtBP1 for degradation [14] . Roscic et al. [15] reported that HIPK2 phosphorylated HPC2 and enhanced its SUMO E3 ligase activity. DNA damage induced HIPK2 activation and phosphorylation of HPC2. HIPK2-mediated HPC2 phosphorylation was required for its SUMO E3 ligase activity, leading to Quantitative analysis of phosphorylated CDC2 band, n = 3; (C) U-2OS cells were transfected with CDC2 firefly reporter plasmid, control renilla vector, and HPC2-V5 or HPC2 site mutation vector as indicated, and cells were lysated and measured luciferase activity after stimulation with arsenate for 24 h; (D) U-2OS cells were transfected with HPC2/T495A-or HPC2/S291A-overexpressing vector. Cells were treated with 5.0 lM arsenate for 48 h and subscribed to Annexin V/PI apoptosis assay; (E) Percentage of apoptotic cells in control, arsenate only, HPC2 T/495A plus arsenate, HPC2/S291A plus arsenate groups were calculated and analyzed; (F) The scheme for proposed mechanism of p38 MAPK signal transduction pathway on regulation of cdc2 expression by phosphorylation of HPC2 and formation of PRC polycomb complex formation and ensuing G2 cell cycle arrest and apoptosis. ***P < 0.001. sumoylation of HIPK2, with sumoylated HIPK2 acting as a transcriptional repressor [15] . Interestingly, the phosphorylation site of HPC2 by HIPK2 was the same as the one we found by p38 MAPK, T495. Roscic et al. [15] did not find that the sumoylation site of HPC2 in the vicinity of lysine 492 was important. On the other hand, our data suggest that mutation of K492 to R totally abolishes arsenate-induced HPC2 and Ring1 binding. Although we cannot exclude the possibility that arsenate might also activate HIPK2, arsenate-induced G2 arrest event in U-2OS cells which are p16 À/À , is different from the 293T cells studied by Roscic et al. [15] . The Rb family is a critical regulator of the cell cycle [16] . One target of Rb family members is E2F transcription factors [17] . E2F binding sites are found, for example, in the promoter region of genes for the cyclin A and E, and cdc2 genes [18] . Binding of Rb to E2F not only masks the transactivation domain of E2F but the Rb-E2F complex that forms at promoters of cell cycle control genes also recruits chromatin-remodeling enzymes such as histone deacetylase (HDAC) to actively repress transcription [19] . The ability of Rb to bind HDAC and to arrest cells in G1 is blocked when Rb is phosphorylated by cyclin D/cdk4 or cdk6 [20] . The cdk inhibitor p16 blocks cdk4/6 activity, leading directly to accumulation of hypophosphorylated Rb and cell cycle arrest [20] .
P16 is not expressed in most normal tissues, but it is up-regulated as a tumor suppressor when the Ras-MAP kinases become constitutively active such as in the case of density-dependent inhibition of cell growth [21] . This growth arrest by p16 eventually leads to a permanent senescence-like withdrawal of the cells from the cell cycle to prevent tumorigenesis [21] . However, p16 is absent or mutated in a lot of tumor cells which result to failing of p16-regulated tumor proliferation suppressor function [22] . Fortunately, Rb not only has HDAC-dependent but also HDAC-independent pathway to regulate cell cycle, which involves HPC2 and Ring1 proteins. They could form a repressive complex to suppress expression of cyclin A and cdc2 and arrest cell in G2 [7] . Using p16 À/À U-2OS cells, we find p38 MAPK phosphorylates HPC2 is required to induce polycomb repression complex formation, CDC2 repression, and irreversible growth arrest (Fig. 7F ) and eventually apoptosis. This finding indicates that it might be possible to use the p38 MAPK pathway as a target against tumors, such as using Ad-MKK6b(E), and genotype screening of p16 and HPC2/T495 expression for patients might be required when using arsenate or MKK6 gene therapy in the future.
